Cite
HARVARD Citation
Ma, C. et al. (2014). Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease. Alimentary pharmacology & therapeutics. 40 (9), pp. 1044-1055. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ma, C. et al. (2014). Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease. Alimentary pharmacology & therapeutics. 40 (9), pp. 1044-1055. [Online].